Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Shattuck Labs, Inc. - Common Stock (NQ: STTK ) 4.680 -0.060 (-1.27%) Streaming Delayed Price Updated: 12:13 PM EDT, Jul 18, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 228,089 Open 4.730 Bid (Size) 4.670 (6) Ask (Size) 4.690 (4) Prev. Close 4.740 Today's Range 4.640 - 4.855 52wk Range 1.330 - 11.76 Shares Outstanding 42,122,778 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Shattuck Labs Announces Addition to Russell 2000® and Russell 3000® Indexes July 01, 2024 From Shattuck Labs, Inc. Via GlobeNewswire Workday To Rally Over 52%? Here Are 10 Top Analyst Forecasts For Thursday June 20, 2024 Via Benzinga Performance YTD -38.10% -38.10% 1 Month -6.02% -6.02% 3 Month -53.29% -53.29% 6 Month -45.52% -45.52% 1 Year +71.43% +71.43% More News Read More Assessing Shattuck Labs: Insights From 6 Financial Analysts June 14, 2024 Via Benzinga Shattuck Labs Announces Updated Positive Interim Data from the Phase 1B Dose Expansion Clinical Trial of SL-172154 in Combination with Azacitidine (AZA) in Frontline Higher-Risk Myelodysplastic Syndromes (HR-MDS) and TP53 mutant (TP53m) Acute Myeloid June 14, 2024 From Shattuck Labs, Inc. Via GlobeNewswire Shattuck Labs Announces Orphan Drug Designation Granted by the U.S. Food and Drug Administration (FDA) for SL-172154 for the Treatment of Acute Myeloid Leukemia (AML) June 10, 2024 From Shattuck Labs, Inc. Via GlobeNewswire Shattuck Labs to Host Investor Call and Webcast on Additional Interim Data Presented at the European Hematology Association (EHA) 2024 Congress from the Phase 1B Dose Expansion Clinical Trial of SL-172154 with Azacitidine (AZA) in Frontline Higher-Risk June 06, 2024 From Shattuck Labs, Inc. Via GlobeNewswire Shattuck Labs to Present Additional Data from the Phase 1B Dose Expansion Clinical Trial of SL-172154 with Azacitidine (AZA) in Frontline Higher-Risk Myelodysplastic Syndromes (HR-MDS) and TP53 mutant (TP53m) Acute Myeloid Leukemia (AML) Patients at the May 14, 2024 From Shattuck Labs, Inc. Via GlobeNewswire STTK Stock Earnings: Shattuck Labs Beats EPS, Beats Revenue for Q1 2024 May 02, 2024 Via InvestorPlace Shattuck Labs Reports First Quarter 2024 Financial Results and Recent Business Highlights May 02, 2024 From Shattuck Labs, Inc. Via GlobeNewswire Shattuck Labs Announces Oral Presentation of Preclinical Data at the American Association for Cancer Research (AACR) Annual Meeting 2024 April 09, 2024 From Shattuck Labs, Inc. Via GlobeNewswire Shattuck Labs Announces Participation in Upcoming 23rd Annual Needham Virtual Healthcare Conference April 01, 2024 From Shattuck Labs, Inc. Via GlobeNewswire Shattuck Labs Announces Appointment of Clay Siegall, Ph.D., and Kate Sasser, Ph.D., to its Board of Directors March 04, 2024 From Shattuck Labs, Inc. Via GlobeNewswire Shattuck Labs Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Business Highlights February 29, 2024 From Shattuck Labs, Inc. Via GlobeNewswire Shattuck Labs Announces Participation in Upcoming March Conferences February 26, 2024 From Shattuck Labs, Inc. Via GlobeNewswire Shattuck Labs Enters into Strategic Collaboration and License Agreement with Ono Pharmaceutical to Generate Bifunctional Fusion Proteins for the Treatment of Autoimmune and Inflammatory Diseases February 13, 2024 From Shattuck Labs, Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Friday's After-Market Session January 19, 2024 Via Benzinga Shattuck Labs Provides Corporate Update and Highlights Upcoming Key Milestones in 2024 January 08, 2024 From Shattuck Labs, Inc. Via GlobeNewswire Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session January 08, 2024 Via Benzinga Shattuck Labs Announces Presentation at Upcoming 42nd Annual J.P. Morgan Healthcare Conference January 04, 2024 From Shattuck Labs, Inc. Via GlobeNewswire Shattuck Labs Announces $50 Million Public Offering of Common Stock and Concurrent Private Placement of Pre-Funded Warrants December 21, 2023 From Shattuck Labs, Inc. Via GlobeNewswire Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet December 15, 2023 Via Benzinga 12 Health Care Stocks Moving In Thursday's Intraday Session December 14, 2023 Via Benzinga Shattuck Labs Inc. (NASDAQ: STTK) Leading the Way in Thursday Trading Based on Percentage Gain December 14, 2023 Via Investor Brand Network Why Nxu Shares Are Trading Higher By Around 42%; Here Are 20 Stocks Moving Premarket December 14, 2023 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday December 14, 2023 Via InvestorPlace Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
